Peer-reviewed journal articles (159)
 
- 1.  Dubois,  N., Van Morckhoven,  D., Tilleman,  L., Van Nieuwerburgh,  F., Bron,  D., Lagneaux,  L., & Stamatopoulos,  B. (2025). Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism. HemaSphere.
- 2.  Van Morckhoven,  D., Dubois,  N., Bron,  D., Meuleman,  N., Lagneaux,  L., & Stamatopoulos,  B. (2023). Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. Frontiers in immunology, 14, 1265969. doi:10.3389/fimmu.2023.1265969
- 3.  Otmani,  K., Rouas,  R., Lagneaux,  L., Krayem,  M., Duvillier,  H., Berehab,  M., & Lewalle,  P. (2023). Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways. Cell Communication and Signaling, 21(1), 253. doi:10.1186/s12964-023-01259-1
- 4.  Draguet,  F., Dubois,  N., Bouland,  C., Pieters,  K., Bron,  D., Meuleman,  N., Stamatopoulos,  B., & Lagneaux,  L. (2023). Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells. Cancers, 15(11), 2901. doi:10.3390/cancers15112901
- 5.  Draguet,  F., Bouland,  C., Dubois,  N., Bron,  D., Meuleman,  N., Stamatopoulos,  B., & Lagneaux,  L. (2023). Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review. Pharmaceutics, 15(2). doi:10.3390/pharmaceutics15020558
- 6.  Massaro,  F., Corrillon,  F., Stamatopoulos,  B., Dubois,  N., Ruer,  A., Meuleman,  N., Bron,  D., & Lagneaux,  L. (2023). Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression. Frontiers in immunology, 14, 1267550. doi:10.3389/fimmu.2023.1267550
- 7.  Maene,  A., Deniz,  G., Bouland,  C., Lagneaux,  L., Philippart,  P., & Buxant,  F. (2022). Suburethral implantation of autologous regenerative cells for female stress urinary incontinence management: Results of a pilot study. European journal of obstetrics, gynecology, and reproductive biology, 278, 38-44. doi:10.1016/j.ejogrb.2022.08.028
- 8.  Bouhtit,  F., Najar,  M., Rahmani,  S., Melki,  R., Najimi,  M., Sadki,  K., Boukhatem,  N., Twizere, J.-C., Meuleman,  N., Lewalle,  P., Lagneaux,  L., & Merimi,  M. (2022). Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases. Inflammation research, 71(7-8), 887-898. doi:10.1007/s00011-022-01573-3
- 9.  Najar,  M., Melki,  R., Khalife,  F., Lagneaux,  L., Bouhtit,  F., Moussa Agha,  D., Fahmi,  H., Lewalle,  P., Fayyad Kazan,  M., & Merimi,  M. (2022). Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Frontiers in Cell and Developmental Biology, 9, 716853. doi:10.3389/fcell.2021.716853
- 10.  Najar,  M., Merimi,  M., Faour,  W.  H., Lombard,  C.  A., Moussa Agha,  D., Ouhaddi,  Y., Sokal,  E.  M., Lagneaux,  L., & Fahmi,  H. (2021). In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway. Pharmaceutics, 13(10). doi:10.3390/pharmaceutics13101736
- 11.  Merimi,  M., El-Majzoub,  R., Lagneaux,  L., Moussa Agha,  D., Bouhtit,  F., Meuleman,  N., Fahmi,  H., Lewalle,  P., Fayyad Kazan,  M., & Najar,  M. (2021). The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.661532
- 12.  Merimi,  M., Buyl,  K., Daassi,  D., Rodrigues,  R.  M., Melki,  R., Lewalle,  P., Vanhaecke,  T., Fahmi,  H., Rogiers,  V., Lagneaux,  L., De Kock,  J., & Najar,  M. (2021). Transcriptional profile of cytokines, regulatory mediators and tlr in mesenchymal stromal cells after inflammatory signaling and cell-passaging. International journal of molecular sciences, 22(14), 7309. doi:10.3390/ijms22147309